Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to investigate the initial dose and dose adjustment range for
paricalcitol injection in patients with chronic kidney disease on hemodialysis who have
secondary hyperparathyroidism.